Clinical Trial

Safety and Immunogenicity Study of Venezuelan Equine Encephalomyelitis (VEE) Vaccine as Booster Vaccine in Adults

Study acronym: VEE
Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated February 16, 2021 (before its estimated December 2023 completion). Its status may not reflect the trial's current state.
Summary
The purpose of this study is to evaluate the safety and immunogenicity of VEE vaccine, C-84, TSI-GSD 205, Lot 7, Run 1, and collect data on the incidence of occupational VEE infection in vaccinated personnel.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2018-05-08; most recent amendment 2022-07-20.
Status change: Not Yet Recruiting → Terminated 2022-07-20
Trial Details
NCT Number NCT03531242
Lead Sponsor U.S. Army Medical Research and Development Command
Conditions Venezuelan Equine Encephalomyelitis
Enrollment 500 participants
Start Date 2021-06
Primary Completion 2023-12 (estimated)
Study Completion 2024-12 (estimated)
Updated on ClinicalTrials.gov 2021-02-16